Linden Advisors’s Translational Development Acquisition Corp Units TDACU Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACU
MF
RCM
MI
WAM
PMAM
SIA
Linden Advisors's TDACU Position: Q1 2025 in Review
Linden Advisors sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 600,000 shares — an estimated $6.02M sold.
Linden Advisors first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $6.02M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.
- Linden Advisors reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
- Linden Advisors sold 600,000 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $6.02M.
- Linden Advisors first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
- Linden Advisors's Translational Development Acquisition Corp Units position peaked at $6.02M in Q4 2024.
- 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.
Based on Linden Advisors's 13F filing for Q1 2025, filed 15 May 2025.